A Comparison of the Malignancy Incidence Among Patients With Psoriatic Arthritis and Patients With Rheumatoid Arthritis in a Large US Cohort

Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs

(2013) Daniel H. Solomon et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides – a follow-up study from the DANBIO Registry

(2012) Lene Dreyer et al.   ANNALS OF THE RHEUMATIC DISEASES

Malignancy validation in a United States registry of rheumatoid arthritis patients

(2012) Mark C Fisher et al.   BMC MUSCULOSKELETAL DISORDERS

Risk of Malignancies in Patients With Rheumatoid Arthritis Treated With Biologic Therapy

(2012) Maria A. Lopez-Olivo et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population

(2012) L. K. Mercer et al.   RHEUMATOLOGY

Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis

(2011) X. Mariette et al.   ANNALS OF THE RHEUMATIC DISEASES

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

(2011) David T. Felson et al.   ARTHRITIS AND RHEUMATISM

The risk of cancer in patients with psoriasis: A population-based cohort study in Taiwan

(2011) Yi-Ju Chen et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: A systematic review and meta-analysis of randomized controlled trials

(2011) Erica D. Dommasch et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology

(2010) W. G. Dixon et al.   ANNALS OF THE RHEUMATIC DISEASES

The risk of cancer in patients with rheumatoid arthritis: A nationwide cohort study in Taiwan

(2010) Yi-Ju Chen et al.   ARTHRITIS AND RHEUMATISM

Comparative Analysis of Disease Activity Measures, Use of Biologic Agents, Body Mass Index, Radiographic Features, and Bone Density in Psoriatic Arthritis and Rheumatoid Arthritis Patients Followed in a Large U.S. Disease Registry

(2010) S. M. REDDY et al.   JOURNAL OF RHEUMATOLOGY

Managing Comorbid Disease in Patients with Psoriatic Arthritis

(2010) M. Elaine Husni et al.   Current Rheumatology Reports

Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor α therapies: Does the risk change with the time since start of treatment?

(2009) Johan Askling et al.   ARTHRITIS AND RHEUMATISM

The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events

(2008) J P Leombruno et al.   ANNALS OF THE RHEUMATIC DISEASES

Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate

(2008) Rachelle Buchbinder et al.   ARTHRITIS AND RHEUMATISM

Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety

(2008) Alberto Alonso-Ruiz et al.   BMC MUSCULOSKELETAL DISORDERS